Toborinone
Toborinone is an inotropic agent. Toborinone increases cAMP and intracellular calcium levels through inhibiting PDE. Toborinone inhibits thrombin-induced platelet aggregation with an IC50 of 9.7 μM[1][2].
Product Specifications
CAS Number
143343-83-3
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Smiles
COC1=C(C=CC(CNCC(COC2=CC=C3C(C=CC(N3)=O)=C2)O)=C1)OC
Molecular Formula
C21H24N2O5
Molecular Weight
384.43
References & Citations
[1]MacGowan G. A. (2000) . Clinical overview of the novel inotropic agent toborinone. Expert opinion on investigational drugs, 9 (5), 1109-1117.|[2]Kageyama, K., et al., (2004) . Toborinone and olprinone, phosphodiesterase III inhibitors, inhibit human platelet aggregation due to the inhibition of both calcium release from intracellular stores and calcium entry. Journal of anesthesia, 18 (2), 107-112.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0951802 1.0 µg DNA
HIGD2A sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details MBS1170308-01 0.02 mg (E-Coli)
Recombinant Arthrobacter chlorophenolicus Phosphoribosyl-ATP pyrophosphatase (hisE)
Sign In for Pricing
View Details MBS1170308-02 0.1 mg (E-Coli)
Recombinant Arthrobacter chlorophenolicus Phosphoribosyl-ATP pyrophosphatase (hisE)
Sign In for Pricing
View Details MBS1170308-03 0.02 mg (Yeast)
Recombinant Arthrobacter chlorophenolicus Phosphoribosyl-ATP pyrophosphatase (hisE)
Sign In for Pricing
View Details